Corindus Vascular Robotics (CVRS)

Corindus Vascular Robotics (CVRS)

Postby investar » Fri Feb 22, 2019 4:01 am

vested in CVRS

maybe it's a good idea to make a separate page for it.

anyway, interesting article on the CorPath GRX:
https://www.therobotreport.com/corpath- ... rosurgery/
investar
Boss' Left Hand Person
 
Posts: 813
Joined: Tue Feb 16, 2010 11:59 pm

Re: Corindus Vascular Robotics (CVRS)

Postby investar » Thu Feb 28, 2019 4:37 am

15m$ raised, without any discount to market price... I like this kind of news: adding a large institutional investor to the investor base

Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American:CVRS), a leading developer of precision vascular robotics, today announced the execution of a private placement transaction with a large institutional investor pursuant to which it will sell and issue an aggregate of 10,872,716 shares of its common stock, at a purchase price of $1.3796 per share, resulting in aggregate gross proceeds to the Company of approximately $15 million, which the Company expects to receive during the day.

The net proceeds are expected to be approximately $14.8 million. The Company intends to use the proceeds for general corporate purposes.
investar
Boss' Left Hand Person
 
Posts: 813
Joined: Tue Feb 16, 2010 11:59 pm

Re: Corindus Vascular Robotics (CVRS)

Postby investar » Sat Mar 16, 2019 5:23 pm

Excellent results, and this stock is starting to run up now!

One of the insiders bought for 800000* as well at the latest financing at 1.38$


Revenue grew 12% to $10.8 million.
The CorPath GRX install base grew 58% to 52 systems worldwide.
Volumes for cassettes -- which are the consumable portion of the CorPath GRX that are used during surgery -- rose 15% to 522.
Gross profit increased more than fivefold to $2.1 million.
Net loss expanded slightly to $35 million.
Cash balance at year-end was $23.8 million. Corindus has since completed a private placement that boosted its bank account by $19.8 million.
There are positive and negative takeaways from these numbers.

The good news is that the CorPath GRX install base is growing quickly and that gross profit is rising fast. The total net loss is relatively steady, too, which is impressive given that the company is scaling out its commercial team.


Target? 5$ in 2020
investar
Boss' Left Hand Person
 
Posts: 813
Joined: Tue Feb 16, 2010 11:59 pm

Re: Corindus Vascular Robotics (CVRS)

Postby investar » Thu Mar 21, 2019 4:18 am

Corindus keeps going higher, momentum is there now, today new high at 2.5$
Very solid volumes

Still the beginning?
investar
Boss' Left Hand Person
 
Posts: 813
Joined: Tue Feb 16, 2010 11:59 pm

Re: Corindus Vascular Robotics (CVRS)

Postby investar » Tue May 07, 2019 4:25 am

Earnings tomorrow! I wonder how much progress will be announced.
presentation;
https://s21.q4cdn.com/154318946/files/d ... y-2019.pdf
investar
Boss' Left Hand Person
 
Posts: 813
Joined: Tue Feb 16, 2010 11:59 pm

Re: Corindus Vascular Robotics (CVRS)

Postby investar » Wed May 08, 2019 4:28 am

9 new systems installed.

Recent Financial Highlights and Business Accomplishments:

Revenue totaled $3.0 million during the first quarter of 2019, including sale and installation of nine CorPath GRX Systems;

Recorded purchase orders for 11 CorPath GRX Systems, an increase of 83% compared to purchase orders received in Q4 2018 and 267% growth compared to the purchase orders received in Q1 2018;

Sold 602 single-use cassettes in the quarter, generating revenue of nearly $0.3 million;

Completed the first-ever clinical robotic-assisted percutaneous coronary intervention (PCI) procedures in Japan in partnership with Takafumi Ueno, MD, PhD, Director of Interventional Cardiology, Center of Cardiovascular Disease, Kurume University Hospital, marking initial enrollment in a post-market study of CorPath GRX;

Received CE mark for a neurovascular indication, allowing the Company to sell neurovascular robots in 33 countries that accept CE mark;

Received an order for the first CorPath GRX System in Italy;

Continued advancement of co-development and co-commercialization partnership discussions to advance the neurovascular robotic platform with remote capabilities; and

Raised approximately $19.8 million in gross proceeds in a private placement sale of unregistered Corindus shares to a large institutional investor and existing investors (Hudson Executive Capital and BioStar Ventures):
investar
Boss' Left Hand Person
 
Posts: 813
Joined: Tue Feb 16, 2010 11:59 pm

Re: Corindus Vascular Robotics (CVRS)

Postby investar » Thu May 09, 2019 6:43 am

nice to see +35% reaction... probably just the beginning
investar
Boss' Left Hand Person
 
Posts: 813
Joined: Tue Feb 16, 2010 11:59 pm

Re: Corindus Vascular Robotics (CVRS)

Postby investar » Wed Jun 19, 2019 1:09 am

Still in nice uptrend, consolidating before next leg up?

“As robotic capabilities continue to advance, we are very pleased to share the latest developments in CorPath GRX with the attendees at EuroPCR,” said Mark Toland, President and Chief Executive Officer of Corindus. “Dr. Fajadet is a pioneer of this technology in Europe and understands our ultimate vision of enhancing patient care through the advancement of our technology. In just a few short months, he has established his facility as a leader in vascular robotics and has demonstrated the positive impact of a high-tech care model to the clinical community in Europe.”

The CorPath System is the world’s only U.S. Food and Drug Administration (FDA) cleared and CE marked robotic platform for percutaneous coronary intervention (PCI) and peripheral vascular intervention (PVI) procedures. CorPath GRX received CE mark for neurovascular intervention in April 2019, broadening the application of the CorPath GRX System to treat all vascular beds in Europe.

“CorPath GRX offers the level of precision and control necessary to perform even the most complex PCI procedures,” said Dr. Fajadet. “The live case went exactly as planned. I was able to complete the procedure with control of all interventional devices and imaging equipment from the control room, providing my patient with high-quality care while protecting myself and the cath lab team. I am pleased to share this technology with my peers to demonstrate how far it has come, and the promising future it may provide patients.”
investar
Boss' Left Hand Person
 
Posts: 813
Joined: Tue Feb 16, 2010 11:59 pm

Re: Corindus Vascular Robotics (CVRS)

Postby investar » Sat Jun 22, 2019 4:11 pm

nice new high on big volume... 4$ is coming sooner rather than later
investar
Boss' Left Hand Person
 
Posts: 813
Joined: Tue Feb 16, 2010 11:59 pm

Re: Corindus Vascular Robotics (CVRS)

Postby investar » Fri Jul 05, 2019 9:01 am

CVRS is now part of the Russell 3000; explains the big volume last week

http://comm.corindus.com/june-2019-corp ... newsletter
investar
Boss' Left Hand Person
 
Posts: 813
Joined: Tue Feb 16, 2010 11:59 pm

Next

Return to A to D

Who is online

Users browsing this forum: No registered users and 8 guests